BIFIDO Co., Ltd. (KOSDAQ:238200)
South Korea · Delayed Price · Currency is KRW 2,620.00
-30.00 (-1.13%)
At close: Oct 2, 2026
BIFIDO Market Cap
BIFIDO has a market cap or net worth of 21.43 billion as of October 2, 2026. Its market cap has decreased by -38.57% in one year.
Market Cap
21.43B
Enterprise Value
24.04B
Revenue
14.63B
Ranking
n/a
PE Ratio
11.57
Stock Price
2,620.00
ChartMarket Cap Chart
Since December 26, 2018, BIFIDO's market cap has decreased from 149.29B to 21.43B, a decrease of -85.64%. That is a compound annual growth rate of -22.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 21.43B | -14.52% |
| Dec 30, 2025 | 25.07B | 4.07% |
| Dec 30, 2024 | 24.09B | -45.16% |
| Dec 28, 2023 | 43.93B | -36.82% |
| Dec 29, 2022 | 69.53B | -22.02% |
| Dec 30, 2021 | 89.16B | -4.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korea Arlico Pharm | 35.10B |
| Pharmsville | 26.82B |
| HLscience | 26.53B |
| Baskhanbio Pharma | 24.53B |
| Seoul Pharma | 22.61B |
| Daesung Microbiological Labs. | 22.57B |
| Hurum | 20.40B |
| Union Korea Pharm | 19.70B |